作者:
Audrey,Aussy [1]
;
Manuel,Fréret [1]
;
Laure,Gallay [2]
;
Didier,Bessis [3]
;
Thierry,Vincent [4]
;
Denis,Jullien [5]
;
Laurent,Drouot [1]
;
Fabienne,Jouen [1]
;
Pascal,Joly [1]
;
Isabelle,Marie [1]
;
Alain,Meyer [6]
;
Jean,Sibilia [6]
;
Brigitte,Bader-Meunier [7]
;
Eric,Hachulla [8]
;
Mohammed,Hamidou [9]
;
Sophie,Huë [10]
;
Jean-Luc,Charuel [11]
;
Nicole,Fabien [2]
;
Pierre-Julien,Viailly [12]
;
Yves,Allenbach [13]
;
Olivier,Benveniste [13]
;
Nadège,Cordel [14]
;
Olivier,Boyer [1]
;
OncoMyositis Study Group
作者单位:
Normandy University, University of Rouen, INSERM U1234, Rouen University Hospital, Rouen, France.
[1]
Édouard Herriot University Hospital, Lyon, France.
[2]
St. Eloi Hospital and Montpellier University Hospital, INSERM U1051, Montpellier, France.
[3]
St. Eloi Hospital and Montpellier University Hospital, Montpellier, France.
[4]
Lyon University and Édouard Herriot University Hospital, Lyon, France.
[5]
Strasbourg University Hospital and Centre de Référence des Maladies Autoimmunes Rares, Strasbourg, France.
[6]
Necker University Hospital, AP-HP, Paris, France.
[7]
European Reference Network on Connective Tissue and Musculoskeletal Diseases, University of Lille, Hospital Claude Huriez, Lille, France.
[8]
Hôtel-Dieu and CHU de Nantes, Nantes, France.
[9]
AP-HP, Henri Mondor Hospital, Créteil, France.
[10]
AP-HP, Pitié-Salpêtrière University Hospital, Paris, France.
[11]
Normandy University, University of Rouen, INSERM U1245, Rouen, France.
[12]
AP-HP, Pitié-Salpêtrière University Hospital, Centre de Référence Maladies Neuro-Musculaires, DHU i2B, INSERM UMRS 974, Paris, France.
[13]
Normandy University, University of Rouen, INSERM U1234, Rouen University Hospital, Rouen, France, and French West Indies University and Pointe-à-Pitre University Hospital, Pointe-à-Pitre, Guadeloupe, France.
[14]
DOI
10.1002/art.40895
PMID
30896088
发布时间
2020-01-30